Construction and validation of a risk-prediction model for chemotherapy-related cognitive impairment in patients with breast cancer

Author:

Liu Yu,Li Ruo-Lin,Chen Lu,Zhao Fu-Yun,Su Ya-Li,Jin Shuai,Liu Jun-E

Funder

Natural Science Foundation of Beijing Municipality

Publisher

Springer Science and Business Media LLC

Reference57 articles.

1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, Bonaventure A, Valkov M, Johnson CJ, Esteve J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP, Group CW. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. https://doi.org/10.1016/S0140-6736(17)33326-3.

2. Emanuel EJ, Gudbranson E, Van Parys J, Gortz M, Helgeland J, Skinner J. Comparing health outcomes of privileged US citizens with those of average residents of other developed countries. JAMA Intern Med. 2021;181:339–44. https://doi.org/10.1001/jamainternmed.2020.7484.

3. Lacourt TE, Heijnen CJ. Mechanisms of neurotoxic symptoms as a result of breast cancer and its treatment: considerations on the contribution of stress, inflammation, and cellular bioenergetics. Curr Breast Cancer Rep. 2017;9:70–81. https://doi.org/10.1007/s12609-017-0245-8.

4. Ono M, Ogilvie JM, Wilson JS, Green HJ, Chambers SK, Ownsworth T, Shum DH. A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Front Oncol. 2015;5:59. https://doi.org/10.3389/fonc.2015.00059.

5. Bender CM, Merriman JD, Sereika SM, Gentry AL, Casillo FE, Koleck TA, Rosenzweig MQ, Brufsky AM, McAuliffe P, Zhu Y, Conley YP. Trajectories of cognitive function and associated phenotypic and genotypic factors in breast cancer. Oncol Nurs Forum. 2018;45:308–26. https://doi.org/10.1188/18.ONF.308-326.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3